Anaphylactoid reactions to dextran 40 and 70: Reports to the US Food and Drug Administration (FDA)

被引：0

作者：

Zinderman, Craig E. ^{[1
]}

Landow, Laurence Landow ^{[1
]}

Wise, Robert P. ^{[1
]}

机构：

[1] US FDA, Ctr Biol Evaluat & Res, Rockville, MD 20857 USA

来源：

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2006年 / 15卷

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

246

引用

页码：S115 / S116

页数：2

共 50 条

[1] Anaphylactoid reactions to Dextran 40 and 70: Reports to the United States Food and Drug Administration, 1969 to 2004
Zinderman, CE
Landow, L
Wise, RP
JOURNAL OF VASCULAR SURGERY, 2006, 43 (05) : 1004 - 1009
[2] ANAPHYLACTOID REACTIONS TO DEXTRAN-70
HEANEY, GAH
BRITISH MEDICAL JOURNAL, 1977, 2 (6100): : 1480 - 1480
[3] SEVERE ANAPHYLACTOID REACTIONS TO DEXTRAN 70
FANOUS, LH
GRAY, A
FELMINGHAM, J
BRITISH MEDICAL JOURNAL, 1977, 2 (6096): : 1189 - 1190
[4] ANAPHYLACTOID REACTIONS ASSOCIATED WITH CLINICAL USE OF DEXTRAN 70
BRISMAN, R
PARKS, LC
HALLER, JA
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1968, 204 (09): : 824 - &
[5] FATAL ANAPHYLACTOID REACTION AFTER DEXTRAN 40 ADMINISTRATION
FLATAU, E
RESNITZKY, P
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 243 (10): : 1035 - 1036
[6] Reports on contrast media reactions: Analysis of data from reports to the US Food and Drug Administration
Lasser, EC
Lyon, SG
Berry, CC
RADIOLOGY, 1997, 203 (03) : 605 - 610
[7] US Food and Drug Administration's (FDA) safety assessment of food ingredients
Thurmond, Scott
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
[8] US Food and Drug Administration (FDA) to conduct a review of the safety of orlistat
Idris, Iskandar
DIABETES OBESITY & METABOLISM, 2009, 11 (11): : 1089 - 1089
[9] Severe Malaria, Pascalian Therapeutics, and the US Food and Drug Administration (FDA)
White, Nicholas J.
Watson, James A.
Simpson, Julie A.
CLINICAL INFECTIOUS DISEASES, 2022, 75 (02) : 358 - 358
[10] Accelerated approval of Iressa from FDA news releases (FDA US Food and Drug Administration)
Shimada, Y
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2003, 33 (07) : 369 - 369

← 1 2 3 4 5 →